Article

Optimized NGS-based de novo MET amplification detection for improved lung cancer patient management

2024-10-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: <italic>MET</italic> amplification (<italic>MET</italic><sup>amp</sup>) is a noteworthy genomic alteration that can occur in patients with non-small cell lung cancer (NSCLC). <italic> </italic>It has been demonstrated to occur as a primary oncogenic driver that may exist prior to any treatment and is referred to as <italic>de novo</italic> <italic>MET</italic><s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0b1a5a14-3a81-504a-ae68-dbd1d1f749a0
DOI: 10.21203/rs.3.rs-5026064/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimized NGS-based de novo MET amplification detection for improved lung cancer patient managementDOI 10.21203/rs.3.rs-5026064/v1Read

Refining patient selection of MET-activated non-small cell lung cancer through biomarker precision.Semantic proximity Read

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsSemantic proximity Read

MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World SettingSemantic proximity Read

Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations.Semantic proximity Read

MET Exon 14 Skipping and Novel Actionable Variants: Diagnostic and Therapeutic Implications in Latin American Non-Small-Cell Lung Cancer Patients.Semantic proximity Read

MET Exon 14 Skipping and Novel Actionable Variants: Diagnostic and Therapeutic Implications in Latin American NSCLC patients.Semantic proximity Read

Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alterationSemantic proximity Read

A Novel Digital PCR Assay for Accurate Detection and Differentiation of Focal and Non-Focal Subtypes of <i>MET</i> Amplification in Lung CancerSemantic proximity Read

Overview of Molecular Detection Technologies for MET in Lung CancerSemantic proximity Read

MET Exon 14 Skipping Mutations in Non–Small-Cell Lung Cancer: Testing Considerations and Clinical Outcomes a 3 years screening experienceSemantic proximity Read

Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumorsSemantic proximity Read

MET alterations in NSCLC-Current Perspectives and Future Challenges.Semantic proximity Read